JP2009526018A5 - - Google Patents

Download PDF

Info

Publication number
JP2009526018A5
JP2009526018A5 JP2008553758A JP2008553758A JP2009526018A5 JP 2009526018 A5 JP2009526018 A5 JP 2009526018A5 JP 2008553758 A JP2008553758 A JP 2008553758A JP 2008553758 A JP2008553758 A JP 2008553758A JP 2009526018 A5 JP2009526018 A5 JP 2009526018A5
Authority
JP
Japan
Prior art keywords
hydroxy
steroidal anti
inflammatory agent
pharmaceutical composition
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008553758A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009526018A (ja
JP5616021B2 (ja
Filing date
Publication date
Priority claimed from GBGB0602778.3A external-priority patent/GB0602778D0/en
Application filed filed Critical
Publication of JP2009526018A publication Critical patent/JP2009526018A/ja
Publication of JP2009526018A5 publication Critical patent/JP2009526018A5/ja
Application granted granted Critical
Publication of JP5616021B2 publication Critical patent/JP5616021B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008553758A 2006-02-10 2007-02-08 ビフェニル−２−イルカルバミン酸１−［２−（２−クロロ−４−｛［（ｒ）−２−ヒドロキシ−２−（８−ヒドロキシ−２−オキソ−１，２−ジヒドロキノリン−５−イル）エチルアミノメチル］｝−５−メトキシフェニルカルバモイル）エチル］ピペリジン−４−イルエステルのコハク酸塩および肺疾患治療におけるその使用 Expired - Fee Related JP5616021B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0602778.3A GB0602778D0 (en) 2006-02-10 2006-02-10 Novel compound
GB0602778.3 2006-02-10
PCT/EP2007/051196 WO2007090859A1 (en) 2006-02-10 2007-02-08 Succinic acid salt of biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{ [ (r)-2-hydroxy-2- (8-hydroxy-2-oxo-1, 2-dihydroquinolin-5-yl) eth ylaminoimethyl] } -5-methoxyphenylcarbamoyl) ethyl] piperidin-4-yl ester and its use for the treatment of pulmonary disorders

Publications (3)

Publication Number Publication Date
JP2009526018A JP2009526018A (ja) 2009-07-16
JP2009526018A5 true JP2009526018A5 (OSRAM) 2010-03-18
JP5616021B2 JP5616021B2 (ja) 2014-10-29

Family

ID=36119909

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008553758A Expired - Fee Related JP5616021B2 (ja) 2006-02-10 2007-02-08 ビフェニル−２−イルカルバミン酸１−［２−（２−クロロ−４−｛［（ｒ）−２−ヒドロキシ−２−（８−ヒドロキシ−２−オキソ−１，２−ジヒドロキノリン−５−イル）エチルアミノメチル］｝−５−メトキシフェニルカルバモイル）エチル］ピペリジン−４−イルエステルのコハク酸塩および肺疾患治療におけるその使用

Country Status (33)

Country Link
US (1) US7960551B2 (OSRAM)
EP (1) EP1981872B1 (OSRAM)
JP (1) JP5616021B2 (OSRAM)
KR (1) KR101488691B1 (OSRAM)
CN (1) CN101379057B (OSRAM)
AR (2) AR059409A1 (OSRAM)
AU (1) AU2007213767B2 (OSRAM)
BR (1) BRPI0707559B8 (OSRAM)
CA (1) CA2641769C (OSRAM)
CR (1) CR10227A (OSRAM)
CY (1) CY1119238T1 (OSRAM)
DK (1) DK1981872T3 (OSRAM)
EA (1) EA016580B1 (OSRAM)
ES (1) ES2640226T3 (OSRAM)
GB (1) GB0602778D0 (OSRAM)
HR (1) HRP20171304T1 (OSRAM)
HU (1) HUE034315T2 (OSRAM)
IL (1) IL193103A (OSRAM)
JO (1) JO3389B1 (OSRAM)
LT (1) LT1981872T (OSRAM)
MA (1) MA30273B1 (OSRAM)
MY (1) MY153656A (OSRAM)
NO (1) NO341343B1 (OSRAM)
NZ (1) NZ570242A (OSRAM)
PE (2) PE20110120A1 (OSRAM)
PL (1) PL1981872T3 (OSRAM)
PT (1) PT1981872T (OSRAM)
SG (1) SG169404A1 (OSRAM)
SI (1) SI1981872T1 (OSRAM)
TW (1) TWI401251B (OSRAM)
UA (1) UA100364C2 (OSRAM)
WO (1) WO2007090859A1 (OSRAM)
ZA (1) ZA200806782B (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1013562B1 (pt) * 2009-04-14 2021-08-03 Glaxo Group Limited Processo para a preparação do composto, e, composto
WO2010123766A1 (en) 2009-04-23 2010-10-28 Theravance, Inc. DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND β2 ADRENERGIC RECEPTOR AGONIST ACTIVITY
AU2015234331B2 (en) * 2009-04-23 2017-08-03 Theravance Biopharma R&D Ip, Llc Diamide compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
WO2011081937A1 (en) 2009-12-15 2011-07-07 Gilead Sciences, Inc. Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy
EP2386555A1 (en) 2010-05-13 2011-11-16 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
ITRM20110083U1 (it) 2010-05-13 2011-11-14 De La Cruz Jose Antonio Freire Piastra per la costruzione di carrelli per aeroplani
AR083115A1 (es) * 2010-09-30 2013-01-30 Theravance Inc Sales oxalato cristalinas de un compuesto diamida
CN103717239B (zh) * 2011-08-02 2017-08-01 希格马托制药工业公司 适合于吸入的氧化抗生物素蛋白的药物组合物
EP2592078A1 (en) 2011-11-11 2013-05-15 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
EP2934594B1 (en) * 2012-12-18 2019-09-04 Almirall, S.A. Cyclohexyl and quinuclidinyl carbamate derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities .
TWI643853B (zh) 2013-02-27 2018-12-11 阿爾米雷爾有限公司 同時具有β2腎上腺素受體促效劑和M3毒蕈鹼受體拮抗劑活性之2-氨基-1-羥乙基-8-羥基喹啉-2(1H)-酮衍生物之鹽類
TWI641373B (zh) 2013-07-25 2018-11-21 阿爾米雷爾有限公司 具有蕈毒鹼受體拮抗劑和β２腎上腺素受體促效劑二者之活性的２－胺基－１－羥乙基－８－羥基喹啉－２（１Ｈ）－酮衍生物之鹽
TW201517906A (zh) 2013-07-25 2015-05-16 Almirall Sa 含有ｍａｂａ化合物和皮質類固醇之組合
TW201617343A (zh) 2014-09-26 2016-05-16 阿爾米雷爾有限公司 具有β２腎上腺素促效劑及Ｍ３蕈毒拮抗劑活性之新穎雙環衍生物
GB201500447D0 (en) * 2015-01-12 2015-02-25 Glaxosmithkline Ip Dev Ltd Novel Combination Product
CN106632257B (zh) * 2016-12-15 2019-02-12 上海市奉贤区中心医院 Gsk961081及其中间体的合成方法
US11484531B2 (en) 2018-08-30 2022-11-01 Theravance Biopharma R&D Ip, Llc Methods for treating chronic obstructive pulmonary disease

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4026897A (en) 1974-01-31 1977-05-31 Otsuka Pharmaceutical Company 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxycarbostyril derivatives
DE3134590A1 (de) 1981-09-01 1983-03-10 Boehringer Ingelheim KG, 6507 Ingelheim Neue benzo-heterocyclen
US4460581A (en) 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
ZW6584A1 (en) 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
US4894219A (en) 1988-03-29 1990-01-16 University Of Florida Beta-agonist carbostyril derivatives, assay method and pharmacological composition
DK443489D0 (da) 1989-09-08 1989-09-08 Ferrosan As Substituerede urinstofforbindelser, deres fremstilling og anvendelse
PT640081E (pt) 1992-03-31 2000-05-31 Glaxo Group Ltd Derivados de fenil-carbamatos e fenil-ureias substituidos sua preparacao e sua utilizacao como antagonistas 5-ht4
CA2123728A1 (en) 1993-05-21 1994-11-22 Noriyoshi Sueda Urea derivatives and their use as acat inhibitors
AU7545894A (en) 1993-09-02 1995-03-22 Yamanouchi Pharmaceutical Co., Ltd. Carbamate derivative and medicine containing the same
KR970701174A (ko) 1994-02-10 1997-03-17 오노다 마사요시 신규한 카바메이트 유도체 및 이의 의약 조성물(Novel carbamate derivative and medicinal composition containing the same)
DE69615214T2 (de) 1995-10-13 2002-06-27 Banyu Pharmaceutical Co., Ltd. Substituierte heteroaromatische derivate
PE92198A1 (es) 1996-08-01 1999-01-09 Banyu Pharma Co Ltd Derivados de 1,4-piperidina disustituida que contienen fluor
US6040344A (en) 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
JP2002508366A (ja) 1997-12-12 2002-03-19 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー キノリンピペラジンおよびキノリンピペリジン誘導体、それらの製造方法、ならびに複合的５−ｈｔ１ａ、５−ｈｔ１ｂおよび５−ｈｔ１ｄ受容体アンタゴニストとしてのそれらの用途
US6713651B1 (en) 1999-06-07 2004-03-30 Theravance, Inc. β2-adrenergic receptor agonists
US6541669B1 (en) 1998-06-08 2003-04-01 Theravance, Inc. β2-adrenergic receptor agonists
JP2002517464A (ja) 1998-06-08 2002-06-18 アドバンスド メディスン インコーポレーテッド ムスカリン性レセプターアンタゴニスト
US6693202B1 (en) 1999-02-16 2004-02-17 Theravance, Inc. Muscarinic receptor antagonists
GB9913083D0 (en) 1999-06-04 1999-08-04 Novartis Ag Organic compounds
US6593497B1 (en) 1999-06-02 2003-07-15 Theravance, Inc. β2-adrenergic receptor agonists
AU783095B2 (en) 1999-12-07 2005-09-22 Theravance Biopharma R&D Ip, Llc Carbamate derivatives having muscarinic receptor antagonist activity
UA73543C2 (uk) 1999-12-07 2005-08-15 Тераванс, Інк. Похідні сечовини, фармацевтична композиція та застосування похідного при приготуванні лікарського засобу для лікування захворювання, яке опосередковується мускариновим рецептором
UA73965C2 (en) 1999-12-08 2005-10-17 Theravance Inc b2 ADRENERGIC RECEPTOR ANTAGONISTS
AU2930501A (en) * 2000-01-07 2001-07-24 Transform Pharmaceuticals, Inc. High-throughput formation, identification, and analysis of diverse solid-forms
PL358057A1 (en) 2000-06-05 2004-08-09 Altana Pharma Ag Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors
AU2002228015B2 (en) 2000-12-22 2007-08-23 Almirall, S.A. Quinuclidine carbamate derivatives and their use as M3 antagonists
GB0103630D0 (en) 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
US20030018019A1 (en) 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
US6653323B2 (en) 2001-11-13 2003-11-25 Theravance, Inc. Aryl aniline β2 adrenergic receptor agonists
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
ATE302774T1 (de) 2002-04-12 2005-09-15 Boehringer Ingelheim Pharma Arzneimittel enthaltend betamimetika und ein neues anticholinergikum
AU2003239880A1 (en) 2002-05-28 2003-12-12 Theravance, Inc. ALKOXY ARYL Beta2 ADRENERGIC RECEPTOR AGONISTS
GB0217225D0 (en) 2002-07-25 2002-09-04 Glaxo Group Ltd Medicinal compounds
TW200410951A (en) 2002-08-06 2004-07-01 Glaxo Group Ltd M3 muscarinic acetylcholine receptor antagonists
PE20040950A1 (es) * 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
US7317102B2 (en) 2003-04-01 2008-01-08 Theravance, Inc. Diarylmethyl and related compounds
WO2004106333A1 (en) 2003-05-28 2004-12-09 Theravance, Inc. Azabicycloalkane compounds as muscarinic receptor antagonists
US7345060B2 (en) 2003-11-21 2008-03-18 Theravance, Inc. Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
US7320990B2 (en) 2004-02-13 2008-01-22 Theravance, Inc. Crystalline form of a biphenyl compound
EP1778626A1 (en) 2004-08-16 2007-05-02 Theravance, Inc. Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
TWI374883B (en) 2004-08-16 2012-10-21 Theravance Inc Crystalline form of a biphenyl compound
EP1833822A2 (en) 2004-08-16 2007-09-19 Theravance, Inc. Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity

Similar Documents

Publication Publication Date Title
JP2009526018A5 (OSRAM)
HRP20171304T1 (hr) Sol s jantarnom kiselinom 1-[2-(2-klor-4-{[(r)-2-hidroksi-2-(8-hidroksi-2-okso-1,2-dihidrokinolin-5-il)etilaminometil]}-5-metoksifenilkarbamoil)etil]piperidin-4-ilnog estera bifenil-2-ilkarbaminske kiseline i njezina upotreba u liječenju plućnih poremećaja
ES2320994T3 (es) Derivados de la quinolina-2-ona para el tratamiento de enfermedades de las vias respiratorias.
CN101903389B (zh) (3-{[[3-(6-氨基-2-丁氧基-8-氧代-7,8-二氢-9h-嘌呤-9-基)丙基](3-(吗啉-4-基)丙基)氨基]甲基}苯基)乙酸甲酯的可药用盐和它们在治疗中的用途
RU2007109598A (ru) Кристаллическая форма бифенильного соединения
JP2022068321A5 (OSRAM)
PL204002B1 (pl) Lek zawierający kortykosteroid oraz zestaw
JP2013538857A5 (OSRAM)
JP2009535340A5 (OSRAM)
CN105025897A (zh) 具有β2肾上腺素能受体激动剂和M3毒蕈碱受体拮抗剂两种活性的2-氨基-1-羟乙基-8-羟基喹啉-2(1H)-酮衍生物的盐
JP2012533550A5 (OSRAM)
JP2010514807A5 (OSRAM)
JP2007526251A (ja) エゼチミベ多形体
JP4508651B2 (ja) ２−フロ酸フルチカゾンの結晶性複合体
CA2552938A1 (en) Combination of benzothiazol-2-one beta2 adrenoceptor agonists and corticosteroids for the treatment of respiratory diseases
TW201217338A (en) Crystalline oxalate salts of a diamide compound
JP2007518767A5 (OSRAM)
HRP20121074T1 (hr) Derivati kinolina i njihovi farmaceutski sastavi
TWI309164B (en) Novel crystal form b of a known thiophenecarboxylic acid dodecahydrocyclopenta[a]phenanthrenyl ester,pharmaceutical composition comprising the same,use thereof, and method of preparing it
JP2010540440A5 (OSRAM)
WO2015062498A1 (zh) 阿利沙坦酯无定形及其制备方法及含所述无定形的药物组合物
US20090280068A1 (en) Polymorph of 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone monohydrochloride
US20090280067A1 (en) Crystal form of 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone monohydrochloride
CN110885351A (zh) 泰拉霉素磷酸盐的晶型及其制备方法
CN106349076A (zh) 阿司匹林丁香酚酯的晶型b及其制备方法